Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Regeneron says monoclonal antibodies prevent Covid-19 in study
Stat
Tue, 01/26/21 - 11:34 am
Regeneron
antibodies
COVID-19
Roche eyes FDA filing after bispecific matches Eylea again
Fierce Biotech
Mon, 01/25/21 - 10:44 am
Roche
bispecifics
Regeneron
Eylea
clinical trials
faricimab
wet age-related macular degeneration
US to pay up to $2.6B for more doses of Regeneron's COVID-19 antibody drug
BioPharma Dive
Wed, 01/13/21 - 11:34 pm
Regeneron
COVID-19
antibodies
government contracts
JPM: Regeneron has spoken with the FDA about odronextamab hold, hopes to get patients back soon
Fierce Biotech
Mon, 01/11/21 - 10:29 am
Regeneron
FDA
odronextamab
clinical hold
B-cell non-Hodgkin lymphoma
Clinical developments over the holidays
EP Vantage
Mon, 01/4/21 - 10:17 am
Aprea Therapeutics
Arcturus Therapeutics
Axsome Therapeutics
Inovio
Regeneron
clinical trials
oncology
vaccines
COVID-19
Regeneron says it will continue trial of COVID antibody cocktail as latest data show positive results
Marketwatch
Wed, 12/30/20 - 10:42 am
Regeneron
COVID-19
antibodies
Roche eyes an uncertain market for faricimab
EP Vantage
Tue, 12/22/20 - 10:49 am
Roche
faricimab
diabetic macular edema
Regeneron
Eylea
Roche's bispecific matches Regeneron's Eylea in phase 3 trials
Fierce Biotech
Mon, 12/21/20 - 11:02 am
Roche
faricimab
diabetic macular edema
clinical trials
Regeneron
Eylea
bispecific antibodies
Lilly and Regeneron COVID-19 antibodies are available all over the U.S. Why aren't they getting to more patients?
Fierce Pharma
Thu, 12/17/20 - 06:19 pm
FDA
Eli Lilly
Regeneron
antibodies
COVID-19
13 drugmakers contracted by Operation Warp Speed in 2020
Beckers Hospital Review
Wed, 12/16/20 - 10:36 pm
HHS
Operation Warp Speed
COVID-19
vaccines
Cytiva
Eli Lilly
AstraZeneca
Emergent BioSolutions
Fujifilm
JNJ
Moderna Therapeutics
Pfizer
BioNTech
Novavax
Regeneron
Sanofi
GSK
Novartis raises the temp on Eylea rivalry with head-to-head trial win for Beovu in diabetic macular edema
Endpoints
Tue, 12/15/20 - 10:51 am
Regeneron
Eylea
Novartis
Beovu
diabetic macular edema
Regeneron's blood cancer hopeful odronextamab hit with FDA partial hold across several trials
Fierce Biotech
Tue, 12/15/20 - 10:49 am
Regeneron
FDA
clinical trials
odronextamab
B-cell non-Hodgkin lymphoma
#ASH20: In a multiple myeloma showdown, Regeneron marches out new PhI data for its BCMA bispecific
Endpoints
Sat, 12/5/20 - 11:34 pm
ASH2020
Regeneron
Multiple Myeloma
clinical trials
REGN5458
Regeneron, UPenn to use gene therapy tools to deliver a COVID-19 antibody drug
BioPharma Dive
Tue, 12/1/20 - 11:32 pm
Regeneron
antibodies
gene therapy
COVID-19
Regeneron COVID-19 drug, used to treat Trump, cleared for emergency use
BioPharma Dive
Sun, 11/22/20 - 11:57 pm
Regeneron
FDA
COVID-19
Emergency Use Authorization
antibodies
Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as IPO rumors heat up
Endpoints
Thu, 11/19/20 - 10:21 am
AbCellera
Eli Lilly
Regeneron
Trianni
monoclonal antibodies
After Pfizer's vaccine data, analysts say COVID19 drugmakers face questions about long-term sales prospects
Fierce Pharma
Mon, 11/9/20 - 08:51 pm
Pfizer
BioNTech
Gilead Sciences
Eli Lilly
Regeneron
COVID-19
pharma stocks
vaccines
clinical trials
Regeneron hopes U.S. will authorize coronavirus antibody drug soon
Yahoo/Reuters
Fri, 11/6/20 - 10:17 am
Regeneron
antibodies
COVID-19
FDA
Regeneron Posts Better-Than-Expected Third-Quarter Earnings
TheStreet.com
Thu, 11/5/20 - 10:50 am
Regeneron
earnings
COVID-19
Regeneron hit by 'safety signal' for COVID-19 cocktail as data board tells pharma to stop enrolling sicker patients
Fierce Biotech
Fri, 10/30/20 - 10:14 am
Regeneron
antibodies
FDA
clinical trials
COVID-19
IDMC
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »